+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Photoselective vaporization of the prostate with the 120-W lithium triborate laser in men taking coumadin



Photoselective vaporization of the prostate with the 120-W lithium triborate laser in men taking coumadin



Urology 78(1): 142-145



To specifically evaluate perioperative morbidity associated with men who were taking coumadin and continued on this medication at therapeutic levels for the purposes of the prostate (PVP). Increasing numbers of men are taking coumadin for medical comorbidity and this creates clinical concerns for urologists treating such men with benign prostatic obstruction. Photoselective vaporization of the PVP has been shown to be an effective treatment for men receiving anticoagulation treatment, although previously published studies have evaluated a mix of men on aspirin, coumadin, or clopidogrel. From a prospective database of men treated with the 120-W lithium triborate (LBO) laser from November 2006 to July 2010, 43 men were identified to have been on coumadin during their PVP. The mean age was 73.4 years (range, 55-90) and mean prostate size was 75.3 mL (range, 20-227). Perioperative morbidity and early functional outcomes were examined. No men required a blood transfusion, although 2 of 43 (4.7%) men had prolonged catheterization for bleeding. No patient required discontinuation of the coumadin during the perioperative period. Urinary tract infection occurred in 4 (9.3%) and recatheterization in 6 (14%). Apart from 3 outliers, the mean postoperative length of stay was 21.6 hours. At 3 months, improvements in International Prostate Symptom Score, peak urinary flow rate, and postvoid residual were similar to previously reported series of men not taking an anticoagulant. PVP in this high-risk group of patients has low perioperative morbidity and is associated with good early functional outcomes.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 054988108

Download citation: RISBibTeXText

PMID: 21459416

DOI: 10.1016/j.urology.2010.12.082


Related references

Photoselective vaporization of the prostate using the 180W lithium triborate laser. Anz Journal of Surgery 82(5): 334-337, 2012

Photoselective vaporization of the prostate using the 120-W lithium triborate laser in enlarged prostates (>120 cc). Bju International 108(6): 860-863, 2011

The massively enlarged prostate: experience with photoselective vaporization of the ≥100 cc prostate using the 180 W lithium triborate laser. Journal of Endourology 29(4): 459-462, 2015

Does prostate size impact upon perioperative outcomes associated with photoselective vaporization of the prostate using the 180W lithium triborate laser?. Urology Annals 7(1): 17-20, 2015

120 W lithium triborate laser for photoselective vaporization of the prostate: comparison with 80 W potassium-titanyl-phosphate laser in an ex-vivo model. Journal of Endourology 24(1): 75-79, 2010

Photoselective vaporization of the prostate with the 120W lithium triborate laser for the treatment of acute urinary retention. Research and Reports in Urology 4: 27-32, 2012

Detrusor overactivity does not predict bothersome storage symptoms after photoselective vaporization of the prostate with lithium triborate laser. Urology 84(4): 898-903, 2014

Early experience photoselective vaporisation of the prostate using the 180W lithium triborate and comparison with the 120W lithium triborate laser. Prostate International 1(1): 42-45, 2013

Assessment of energy density usage during 180W lithium triborate laser photoselective vaporization of the prostate for benign prostatic hyperplasia. Is there an optimum amount of kilo-Joules per gram of prostate?. Bju International 118(4): 633-640, 2016

Can preopeative detrusor underactivity have an impact on surgical outcomes of laser prostatectomy: Comparison in serial 3-year follow-up outcomes between 120-W lithium triborate photoselective vaporization of the prostate (PVP) and holmium laser enucleation of the prostate (HoLEP). European Urology Suppl.s 16(3): E505-E506, 2017

Photoselective vaporization of the prostate using GreenLight 120-W lithium triborate laser to treat symptomatic benign prostatic hyperplasia: A single-centre prospective study. Canadian Urological Association Journal 7(3-4): E193-E196, 2012

Greenlight photoselective 120-watt 532-nm lithium triborate laser vaporization prostatectomy in living canines. Journal of Endourology 23(5): 837-845, 2009

Photoselective vaporization for prostatic obstruction with the 120-W lithium triborate laser: 1-year clinical outcomes. International Journal of Urology 18(2): 162-165, 2011

Catheter-free 120W lithium triborate (LBO) laser photoselective vaporization prostatectomy (PVP) for benign prostatic hyperplasia (BPH). Lasers in Surgery and Medicine 40(8): 529-534, 2008

Lithium triborate (LBO) laser photoselective vaporization prostatectomy (PVP) for symptomatic benign prostatic hyperplasia (BPH): Initial outcomes. European Urology Suppl.s 7(3): 203, 2008